It is time for physicians to embrace cost-effectiveness and cost utility analysis research in the treatment of spinal pain
To access this article, please choose from the options below
FDA device/drug status: not applicable.Nothing of value received from a commercial entity related to this manuscript.
PII: S1529-9430(05)00106-3
doi:10.1016/j.spinee.2005.03.001
© 2005 Elsevier Inc. All rights reserved.
